NEW
YORK, May 27, 2024 /PRNewswire/ -- IFF
(NYSE: IFF), a global leader in food and beverage, home and
personal care and health will unveil groundbreaking study results
at upcoming major biomedical conferences. These results highlight
how IFF Pharma Solutions NovaMatrix® portfolio of
ultrapure alginate biopolymers could revolutionize regenerative
medicine and 3D cell culture applications. At the 12th
World Biomaterials Congress (WBC), IFF Pharma Solutions will
showcase a first-of-its-kind alginate hydrogel system that
self-gels, offering a minimally invasive way to deliver
therapeutics. The company will then reveal how its unique porous
alginate foam scaffolds can be utilized for 3D cell culture at the
TERMIS World Congress.
Breakthrough alginate hydrogel system in the spotlight at
WBC
At WBC in Daegu, South Korea,
May 26-31, booth #74, visitors will
learn how IFF is breaking boundaries in the biotech space with
novel alginate biopolymer technologies. During a poster session on
May 28 at 06:00 PM (Korean standard time), Caroline Cooreman, global business development
& product manager, Biotechnology, IFF Pharma
Solutions, will reveal groundbreaking alginate hydrogel system
that self-gels within minutes after injection. This is enabled by
combining a calcium alginate suspension with soluble sodium
alginate. The resulting self-gelling hydrogel system could
transform regenerative medicine by providing a minimally invasive
alternative to surgical implantation procedures for delivering
therapeutic cells, proteins, or drugs.
"Our revolutionary self-gelling technology is just one aspect of
our alginate innovation that we're illuminating at WBC," said
Caroline Cooreman. "Through our
unmatched polymer expertise and rigorous research, we understand
how to tailor the viscosity and strength of our alginate gels by
selecting specific alginate monomer compositions and molecular
weights. This allows us to create custom gels optimized for our
customers' unique formulation needs."
Pioneering alginate foam scaffolds to be featured at
TERMIS
IFF will continue its alginate innovation showcase just weeks
later at the 7th TERMIS World Congress in Seattle, Washington, June 25-28. Mark
Dreibelbis, senior scientist, IFF Pharma Solutions, will
reveal pioneering macro-porous alginate foam scaffolds for 3D cell
culture on Wednesday June 26, at
7:05 PM PDT in Hall 4A with a
follow-up on Thursday, June 27, at
6:15 PM PDT in Hall 4A. The
presentation titled, Macroporous Alginate Foam Scaffolds for 3D
Cell Growth will be part of the theater and poster sessions at
the conference.
Leveraging its deep expertise in alginates and customization
capabilities, IFF has tuned the foam scaffolds to achieve 3D
culture conditions for various cell types based on customer needs.
By offering practical methods for cell seeding and release, the
alginate foams offer a non-animal-based cell culture environment
which could support tissue engineering and therapeutic screening
applications.
"As the only supplier of ultrapure and sterile alginates, we're
excited about how our industry leading NovaMatrix®
portfolio is propelling the biotech field forward," added Caroline.
"The latest research we're revealing at WBC and TERMIS will provide
our customers with transformative solutions for next-generation
biotherapeutics – from controlled hydrogel technologies to advanced
3D cell culture platforms. Looking ahead, we will continue to
actively research and advance the impact that our high-quality
alginate polymers can bring to further support our customers in the
biomedical industry."
For more information about IFF's industry-leading portfolio of
ultrapure NovaMatrix® biopolymers, visit IFF Pharma
Solutions and stop by at either of IFF's upcoming events or tune in
to our June 5 webinar, "Advancing
cell therapy: innovations in polymer-based encapsulation and
delivery". Register here.
Welcome to IFF
At IFF (NYSE: IFF), an industry leader in food, beverage,
health, biosciences and scent, science and creativity meet to
create essential solutions for a better world – from global icons
to unexpected innovations and experiences. With the beauty of art
and the precision of science, we are an international collective of
thinkers who partners with customers to bring scents, tastes,
experiences, ingredients and solutions for products the world
craves. Together, we will do more good for people and planet. Learn
more at iff.com, X
(Twitter) , Facebook, Instagram,
and LinkedIn.
©2024 International Flavors & Fragrances Inc. (IFF). IFF,
the IFF Logo, and all trademarks and service marks denoted with
TM, SM or ® are owned by IFF or affiliates of
IFF unless otherwise noted. All Rights Reserved.
Contact:
Reena Chaudhary
Global Communications Manager
+91 9769820494
reena.chaudhary@iff.com
SOURCE IFF